As in the melanoma and breast cancer system we could demonstrate that IFNβ upregulated expression of TRAIL and that IFNβ-induced apoptosis could be inhibited by an anti-TRAIL-antibody and TRAIL-siRNA [19–20]. This evidence concerns the gene IFNB1 and breast carcinoma.